460 related articles for article (PubMed ID: 18242313)
1. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
2. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Hematol Oncol Clin North Am; 2010 Feb; 24(1):1-18. PubMed ID: 20113893
[TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
4. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
6. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Balduzzi A; De Lorenzo P; Schrauder A; Conter V; Uderzo C; Peters C; Klingebiel T; Stary J; Felice MS; Magyarosy E; Schrappe M; Dini G; Gadner H; Valsecchi MG
Haematologica; 2008 Jun; 93(6):925-9. PubMed ID: 18413892
[TBL] [Abstract][Full Text] [Related]
7. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pediatric acute lymphoblastic leukemia.
Tucci F; Aricò M
Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
[No Abstract] [Full Text] [Related]
10. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
11. [High-risk acute lymphoblastic leukemia].
Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
[No Abstract] [Full Text] [Related]
12. Building better therapy for children with acute lymphoblastic leukemia.
Carroll WL; Raetz EA
Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
[TBL] [Abstract][Full Text] [Related]
13. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia.
Rice SC; Vacek P; Homans AH; Messier T; Rivers J; Kendall H; Finette BA
Cancer Res; 2004 Jul; 64(13):4464-71. PubMed ID: 15231655
[TBL] [Abstract][Full Text] [Related]
15. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
16. Treatment of childhood acute lymphoblastic leukemia.
Stanulla M; Schrappe M
Semin Hematol; 2009 Jan; 46(1):52-63. PubMed ID: 19100368
[TBL] [Abstract][Full Text] [Related]
17. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan.
Mitsui T; Mori T; Fujita N; Inada H; Horibe K; Tsurusawa M;
Pediatr Blood Cancer; 2009 May; 52(5):591-5. PubMed ID: 19156862
[TBL] [Abstract][Full Text] [Related]
19. [Results of the treatment for infant acute lymphoblastic leukemia treated in the program Dana-Faber Cancer Institute. Report of Polish Pediatric Study Group for Leukemia and Lymphoma].
Sońta-Jakimczyk D; Olejnik I; Armata J; Bogusławska-Jaworska J; Kołecki P; Kowalczyk J; Rokicka-Milewska R; Chybicka A; Derwich K; Drabko K; Hicke-Roberts A; Kubiczek K; Steczowicz M
Wiad Lek; 1998; 51 Suppl 4():52-8. PubMed ID: 10731944
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of childhood acute lymphoblastic leukemia.
Brenner TL; Pui CH; Evan WE
Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
